{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:57:32Z","timestamp":1777874252572,"version":"3.51.4"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005633","name":"Finnish Foundation for Cardiovascular Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital","award":["T63264"],"award-info":[{"award-number":["T63264"]}]},{"name":"Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital","award":["T66774"],"award-info":[{"award-number":["T66774"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Primary aldosteronism is a common but underdiagnosed cause of secondary hypertension, characterized by volume overload. Bioimpedance spectroscopy is widely used to assess fluid status in dialysis patients. We examined whether this method can distinguish primary aldosteronism from essential hypertension (EH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Patients with confirmed primary aldosteronism (n = 77), EH (n = 90), and normotensive controls (n = 79) were prospectively recruited for a cross-sectional comparison.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Total body water, extracellular and intracellular water, and overhydration were measured using bioimpedance spectroscopy. Analyses were adjusted for sex, age, body surface area, estimated glomerular filtration rate, diuretic or spironolactone use, and comorbid diabetes or heart failure. Routine laboratory and hormonal tests were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Extracellular water (ECW) volume was 0.69 \u00b1 1.04 and 0.88 \u00b1 1.04 L\/m2 higher, and overhydration 0.76 \u00b1 1.4 and 0.92 \u00b1 1.4 L greater, in primary aldosteronism than in EH and normotensive controls, respectively (P &amp;lt; .001 for all). Total body water did not differ significantly among groups (21.3 \u00b1 2.2, 21.0 \u00b1 2.8, and 21.6 \u00b1 2.4 L\/m2, respectively; P = .083). Plasma N-terminal pro\u2013atrial natriuretic peptide concentration was highest in primary aldosteronism. Primary aldosteronism severity correlated positively with ECW volume (rS = 0.31), overhydration (rS = 0.43), and extracellular-to-intracellular water ratio (rS = 0.36; P &amp;lt; .01 for all).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ECW overload in primary aldosteronism can be assessed using bioimpedance spectroscopy. Further research should determine whether addition of this method to current approaches can improve diagnostic accuracy for primary aldosteronism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvag070","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:41:46Z","timestamp":1776944506000},"page":"578-589","source":"Crossref","is-referenced-by-count":0,"title":["Bioimpedance spectroscopy uncovers extracellular fluid excess in primary aldosteronism"],"prefix":"10.1093","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9720-5026","authenticated-orcid":false,"given":"Marianna","family":"Viukari","sequence":"first","affiliation":[{"name":"Endocrinology, Helsinki University Hospital and University of Helsinki , 00029 Helsinki ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8382-7737","authenticated-orcid":false,"given":"Antero","family":"Yl\u00e4nen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tampere University Hospital , 33521 Tampere ,","place":["Finland"]},{"name":"Faculty of Medicine and Health Technology, Tampere University , 33014 Tampere ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7806-8190","authenticated-orcid":false,"given":"Eeva","family":"Kokko","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health Technology, Tampere University , 33014 Tampere ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9768-7923","authenticated-orcid":false,"given":"Lauri","family":"Suojanen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tampere University Hospital , 33521 Tampere ,","place":["Finland"]},{"name":"Faculty of Medicine and Health Technology, Tampere University , 33014 Tampere ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8577-0316","authenticated-orcid":false,"given":"Eeva","family":"Moilanen","sequence":"additional","affiliation":[{"name":"The Immunopharmacology Research Group, Tampere University and Tampere University Hospital , 33014 Tampere ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0041-1240","authenticated-orcid":false,"given":"Niina","family":"Matikainen","sequence":"additional","affiliation":[{"name":"Endocrinology, Helsinki University Hospital and University of Helsinki , 00029 Helsinki ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7397-6122","authenticated-orcid":false,"given":"Pasi I","family":"Nevalainen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tampere University Hospital , 33521 Tampere ,","place":["Finland"]},{"name":"Faculty of Medicine and Health Technology, Tampere University , 33014 Tampere ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4614-4347","authenticated-orcid":false,"given":"Esa","family":"H\u00e4m\u00e4l\u00e4inen","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, University of Helsinki , 00014 Helsinki ,","place":["Finland"]},{"name":"Department of Clinical Chemistry, University of Eastern Finland , 70211 Kuopio ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4905-7564","authenticated-orcid":false,"given":"Ilkka","family":"P\u00f6rsti","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tampere University Hospital , 33521 Tampere ,","place":["Finland"]},{"name":"Faculty of Medicine and Health Technology, Tampere University , 33014 Tampere ,","place":["Finland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"9","key":"2026043015231583500_lvag070-B1","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: an endocrine society clinical practice guideline","volume":"110","author":"Adler","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"2026043015231583500_lvag070-B2","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2026043015231583500_lvag070-B3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"issue":"9628","key":"2026043015231583500_lvag070-B4","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"The Lancet"},{"issue":"9","key":"2026043015231583500_lvag070-B5","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1097\/HJH.0000000000002441","article-title":"Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension","volume":"38","author":"Parasiliti-Caprino","year":"2020","journal-title":"J Hypertens"},{"issue":"1","key":"2026043015231583500_lvag070-B6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2026043015231583500_lvag070-B7","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/HJH.0000000000002250","article-title":"Atrial fibrillation as presenting sign of primary aldosteronism: results of the Prospective Appraisal on the Prevalence of Primary Aldosteronism in Hypertensive (PAPPHY) study","volume":"38","author":"Seccia","year":"2020","journal-title":"J Hypertens"},{"issue":"3","key":"2026043015231583500_lvag070-B8","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"Observational study mortality in treated primary aldosteronism","volume":"60","author":"Reincke","year":"2012","journal-title":"Hypertension"},{"issue":"1","key":"2026043015231583500_lvag070-B9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","article-title":"Renal damage in primary aldosteronism: a systematic review and meta-analysis","volume":"38","author":"Monticone","year":"2020","journal-title":"J Hypertens"},{"key":"2026043015231583500_lvag070-B10","doi-asserted-by":"publisher","first-page":"101226","DOI":"10.1016\/j.lanepe.2025.101226","article-title":"Adrenal aldosterone synthase (CYP11B2) histopathology and its association with disease-induced sudden death: a cross-sectional study","volume":"51","author":"Yl\u00e4nen","year":"2025","journal-title":"Lancet Reg Health Eur."},{"issue":"3","key":"2026043015231583500_lvag070-B11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1053\/j.ajkd.2023.01.447","article-title":"Underdiagnosis of primary aldosteronism: a review of screening and detection","volume":"82","author":"Funes Hernandez","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2026043015231583500_lvag070-B12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1161\/HYPERTENSIONAHA.121.18118","article-title":"Screening rates for primary aldosteronism among individuals with hypertension plus hypokalemia: a population-based retrospective cohort study","volume":"79","author":"Hundemer","year":"2022","journal-title":"Hypertension"},{"issue":"7","key":"2026043015231583500_lvag070-B13","doi-asserted-by":"publisher","first-page":"bvae109","DOI":"10.1210\/jendso\/bvae109","article-title":"Challenges in diagnosing and managing the spectrum of primary aldosteronism","volume":"8","author":"Yang","year":"2024","journal-title":"J Endocr Soc"},{"issue":"8","key":"2026043015231583500_lvag070-B14","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1210\/clinem\/dgab348","article-title":"Performance of the aldosterone to renin ratio as a screening test for primary aldosteronism","volume":"106","author":"Hung","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026043015231583500_lvag070-B15","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1161\/HYPERTENSIONAHA.122.19377","article-title":"Performance of confirmatory tests for diagnosing primary aldosteronism: a systematic review and meta-analysis","volume":"79","author":"Leung","year":"2022","journal-title":"Hypertension"},{"issue":"7","key":"2026043015231583500_lvag070-B16","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026043015231583500_lvag070-B17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/ejendo\/lvaf124","article-title":"A global real-world study assessing total time to adrenalectomy in primary aldosteronism","volume":"193","author":"Ter","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2026043015231583500_lvag070-B18","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1152\/physrev.00026.2015","article-title":"Primary aldosteronism: changing definitions and new concepts of physiology and pathophysiology both inside and outside the kidney","volume":"96","author":"Stowasser","year":"2016","journal-title":"Physiol Rev"},{"issue":"6","key":"2026043015231583500_lvag070-B19","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"issue":"2","key":"2026043015231583500_lvag070-B20","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1093\/eurjpc\/zwaa108","article-title":"Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study","volume":"29","author":"Rossi","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"2026043015231583500_lvag070-B21","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S2213-8587(18)30071-8","article-title":"Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies","volume":"6","author":"Williams","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2026043015231583500_lvag070-B22","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1097\/HJH.0000000000003696","article-title":"Volume overload is a major characteristic in primary aldosteronism: a 3-year follow-up study","volume":"42","author":"Kokko","year":"2024","journal-title":"J Hypertens"},{"issue":"5","key":"2026043015231583500_lvag070-B23","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1161\/HYPERTENSIONAHA.109.141531","article-title":"Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study","volume":"55","author":"Gaddam","year":"2010","journal-title":"Hypertension"},{"issue":"11","key":"2026043015231583500_lvag070-B24","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/archinte.168.11.1159","article-title":"Characterization of resistant hypertensionassociation between resistant hypertension, aldosterone, and persistent intravascular volume expansion","volume":"168","author":"Gaddam","year":"2008","journal-title":"Arch Intern Med"},{"issue":"2","key":"2026043015231583500_lvag070-B25","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1172\/JCI104269","article-title":"Body fluid and electrolyte composition in arterial hypertension. II. Studies in mineralocorticoid hypertension*","volume":"40","author":"Chobanian","year":"1961","journal-title":"J Clin Invest"},{"issue":"11","key":"2026043015231583500_lvag070-B26","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1253\/jcj.48.1184","article-title":"Effect of spironolactone on fluid volumes and adrenal steroids in primary aldosteronism","volume":"48","author":"Ichikawa","year":"1984","journal-title":"Jpn Circ J"},{"issue":"1","key":"2026043015231583500_lvag070-B27","doi-asserted-by":"publisher","first-page":"15297","DOI":"10.1038\/srep15297","article-title":"Effect of treatment on body fluid in patients with unilateral aldosterone producing adenoma: adrenalectomy versus spironolactone","volume":"5","author":"Wu","year":"2015","journal-title":"Sci Rep"},{"issue":"2","key":"2026043015231583500_lvag070-B28","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41440-024-01997-w","article-title":"Antihypertensive effects and changes in extracellular water content by mineralocorticoid receptor antagonists in patients with primary aldosteronism","volume":"48","author":"Matsuda","year":"2025","journal-title":"Hypertens Res"},{"issue":"1","key":"2026043015231583500_lvag070-B29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/joim.13115","article-title":"Primary aldosteronism: higher volume load, cardiac output and arterial stiffness than in essential hypertension","volume":"289","author":"Choudhary","year":"2021","journal-title":"J Intern Med"},{"issue":"2","key":"2026043015231583500_lvag070-B30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1053\/j.jrn.2015.10.001","article-title":"Longitudinal changes in body composition in patients after initiation of hemodialysis therapy: results from an international cohort","volume":"26","author":"Marcelli","year":"2016","journal-title":"J Ren Nutr Off J Counc Ren Nutr Natl Kidney Found"},{"issue":"5","key":"2026043015231583500_lvag070-B31","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026043015231583500_lvag070-B32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin c","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"issue":"1-2","key":"2026043015231583500_lvag070-B33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jchromb.2007.11.005","article-title":"Determination of aldosterone in serum by liquid chromatography\u2013tandem mass spectrometry","volume":"862","author":"Turpeinen","year":"2008","journal-title":"J Chromatogr B"},{"issue":"10","key":"2026043015231583500_lvag070-B34","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"J Hypertens"},{"issue":"11","key":"2026043015231583500_lvag070-B35","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1093\/ajh\/hpae087","article-title":"Targeted treatment reverses increased left cardiac work in unilateral vs. bilateral primary aldosteronism","volume":"37","author":"Kokko","year":"2024","journal-title":"Am J Hypertens"},{"issue":"1","key":"2026043015231583500_lvag070-B36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/ejendo\/lvaf117","article-title":"Expert consensus on the primary aldosteronism severity classification and its strategic application in indicating adrenal venous sampling","volume":"193","author":"Murakami","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2026043015231583500_lvag070-B37","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1088\/0967-3334\/27\/9\/012","article-title":"Body fluid volume determination via body composition spectroscopy in health and disease","volume":"27","author":"Moissl","year":"2006","journal-title":"Physiol Meas"},{"issue":"1","key":"2026043015231583500_lvag070-B38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/ajcn\/85.1.80","article-title":"A whole-body model to distinguish excess fluid from the hydration of major body tissues","volume":"85","author":"Chamney","year":"2007","journal-title":"Am J Clin Nutr"},{"issue":"6_2","key":"2026043015231583500_lvag070-B39","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/archinte.1916.00080130010002","article-title":"A formula to estimate the approximate surface area if height and weight be known","volume":"17","author":"Du Bois","year":"1916","journal-title":"Arch Intern Med"},{"issue":"4","key":"2026043015231583500_lvag070-B40","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"issue":"6","key":"2026043015231583500_lvag070-B41","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr Rev"},{"issue":"1-2","key":"2026043015231583500_lvag070-B42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000368264","article-title":"Mineralocorticoid-induced sodium appetite and renal salt retention: evidence for common signaling and effector mechanisms","volume":"128","author":"Fu","year":"2014","journal-title":"Nephron Physiol"},{"issue":"1","key":"2026043015231583500_lvag070-B43","doi-asserted-by":"publisher","first-page":"10947","DOI":"10.1038\/s41598-017-11468-7","article-title":"Voluntary liquorice ingestion increases blood pressure via increased volume load, elevated peripheral arterial resistance, and decreased aortic compliance","volume":"7","author":"Hautaniemi","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"2026043015231583500_lvag070-B44","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1093\/cvr\/cvab363","article-title":"New understanding of circulatory blood flow and arterial blood pressure mechanisms","volume":"118","author":"Wolff","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"5","key":"2026043015231583500_lvag070-B45","doi-asserted-by":"publisher","first-page":"R945","DOI":"10.1152\/ajpregu.00363.2017","article-title":"Mechanisms of sodium balance: total body sodium, surrogate variables, and renal sodium excretion","volume":"315","author":"Bie","year":"2018","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"issue":"6","key":"2026043015231583500_lvag070-B46","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1001\/jamasurg.2021.0254","article-title":"Outcomes of a specialized clinic on rates of investigation and treatment of primary aldosteronism","volume":"156","author":"Liu","year":"2021","journal-title":"JAMA Surg"},{"issue":"38","key":"2026043015231583500_lvag070-B47","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension: developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO)","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"2","key":"2026043015231583500_lvag070-B48","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/jch.14173","article-title":"The effect of medication on the aldosterone-to-renin ratio. A critical review of the literature","volume":"23","author":"Alnazer","year":"2021","journal-title":"J Clin Hypertens"},{"issue":"1","key":"2026043015231583500_lvag070-B49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2215\/CJN.03610414","article-title":"Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD","volume":"10","author":"Tsai","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"2026043015231583500_lvag070-B50","doi-asserted-by":"publisher","first-page":"e001918","DOI":"10.1161\/JAHA.115.001918","article-title":"Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies","volume":"4","author":"Hung","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"2026043015231583500_lvag070-B51","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1093\/ndt\/gfn707","article-title":"The mortality risk of overhydration in haemodialysis patients","volume":"24","author":"Wizemann","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"2026043015231583500_lvag070-B52","doi-asserted-by":"publisher","first-page":"1388591","DOI":"10.3389\/fnut.2024.1388591","article-title":"High sodium intake and fluid overhydration predict cardiac structural and functional impairments in chronic kidney disease","volume":"11","author":"Duan","year":"2024","journal-title":"Front Nutr"},{"issue":"2","key":"2026043015231583500_lvag070-B53","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3390\/nu13020650","article-title":"Association between daily urinary sodium excretion, ratio of extracellular water-to-total body water ratio, and kidney outcome in patients with chronic kidney disease","volume":"13","author":"Kohatsu","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"2026043015231583500_lvag070-B54","doi-asserted-by":"publisher","first-page":"e57511","DOI":"10.1371\/journal.pone.0057511","article-title":"Aldosterone and mortality in hemodialysis patients: role of volume overload","volume":"8","author":"Hung","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"2026043015231583500_lvag070-B55","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000345243","article-title":"Vascular actions of aldosterone","volume":"50","author":"Briet","year":"2012","journal-title":"J Vasc Res"},{"issue":"8","key":"2026043015231583500_lvag070-B56","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrneph.2013.110","article-title":"Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis","volume":"9","author":"Brown","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"2026043015231583500_lvag070-B57","doi-asserted-by":"publisher","first-page":"761848","DOI":"10.3389\/fnut.2022.761848","article-title":"Impact of overhydration on left ventricular hypertrophy in patients with chronic kidney disease","volume":"9","author":"Sun","year":"2022","journal-title":"Front Nutr"},{"issue":"1-3","key":"2026043015231583500_lvag070-B58","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000485153","article-title":"Fluid overload and inflammation axis","volume":"45","author":"Dekker","year":"2018","journal-title":"Blood Purif"},{"issue":"3","key":"2026043015231583500_lvag070-B59","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1210\/er.2003-0006","article-title":"Cardiac hormones as diagnostic tools in heart failure","volume":"24","author":"Ruskoaho","year":"2003","journal-title":"Endocr Rev"},{"issue":"7","key":"2026043015231583500_lvag070-B60","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/eurheartj\/eht466","article-title":"Natriuretic peptides in cardiovascular diseases: current use and perspectives","volume":"35","author":"Volpe","year":"2014","journal-title":"Eur Heart J"},{"issue":"2","key":"2026043015231583500_lvag070-B61","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s12020-014-0316-9","article-title":"Pathophysiological functions of adrenomedullin and natriuretic peptides in patients with primary aldosteronism","volume":"48","author":"Hu","year":"2015","journal-title":"Endocrine"},{"issue":"3","key":"2026043015231583500_lvag070-B62","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.amjhyper.2004.09.016","article-title":"Atrial and brain natriuretic peptides as markers of cardiac load and volume retention in primary aldosteronism","volume":"18","author":"Kato","year":"2005","journal-title":"Am J Hypertens"},{"issue":"5","key":"2026043015231583500_lvag070-B63","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1080\/08037050601037760","article-title":"Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration","volume":"15","author":"Jakubik","year":"2006","journal-title":"Blood Press"},{"issue":"11","key":"2026043015231583500_lvag070-B64","doi-asserted-by":"publisher","first-page":"e3832","DOI":"10.1210\/clinem\/dgaf129","article-title":"Subclinical primary aldosteronism is characterized by maladaptive natriuretic peptide and adrenal hormonal physiology","volume":"110","author":"Parisien-La Salle","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026043015231583500_lvag070-B65","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/s41440-020-0529-7","article-title":"Abdominal aortic calcification is more severe in unilateral primary aldosteronism patients and is associated with elevated aldosterone and parathyroid hormone levels","volume":"43","author":"Tuersun","year":"2020","journal-title":"Hypertens Res"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag070\/68172453\/lvag070.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/5\/578\/68172453\/lvag070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/5\/578\/68172453\/lvag070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:23:23Z","timestamp":1777577003000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/194\/5\/578\/8663730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag070","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,27]]}}}